Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-67.98	221.25	690.99
Graham Fair Price	-43.43	6.62	11.70
PEG	516.94	1.80	-0.29
Price/Book	-18.55	2.43	2.98
Price/Cash Flow	13.59	332.85	293.04
Prices/Earnings	-166.47	-123.01	-46.16
Price/Sales	-24.77	21.39	28.44
Price/FCF	13.59	332.85	293.04
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	1.33	0.77	0.76
Operating Margin	61.60	-0.09	-0.22
ROA	69.28	< 0.005	-0.01
ROE	-0.02	< 0.005	69.43
ROIC	-0.02	< 0.005	55.45
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.01	-0.04	-71.82
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.98	0.57	-41.76
EPS QOQ	-1.58	0.68	-56.81
FCF QOQ	0.35	-0.26	-26.09
Revenue QOQ	-0.04	0.12	161.60
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	80.61	-3.66	-95.46
Days Sales Outstanding (DSO)	18.23	17.01	-6.66
Inventory Turnover	1.12	-24.60	2103.30
Debt/Capitalization	0.29	0.27	-4.97
Quick Ratio	2.99	3.02	0.81
Naive Interpretation	member

04 - Leverage & Liquidity · Balanced

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	19.43	19.88	2.31
Cash	12.06	12.44	3.15
Capex	-0.17	-0.20	-14.16
Free Cash Flow	0.20	0.14	-26.63
Revenue	2.03	2.25	10.78
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	3.24	3.32	2.33
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	17.00	7.72	-54.61
Naive Interpretation	Member

06 - Financial Health · Bad

Rating